ArticleVaccines2023

Evaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2.

Lorenzo Islas-Vazquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.